Tag results:
p21
Pulmonary Cell News
A cGAS-Dependent Response Links DNA Damage and Senescence in Alveolar Epithelial Cells: A Potential Drug Target in IPF
[American Journal of Physiology-Lung Cellular and Molecular Physiology] Scientists investigated the role of the DNA-sensing GMP-AMP synthase in idiopathic pulmonary fibrosis, with a focus on alveolar epithelial cell senescence.
Cancer Stem Cell News
Down-Regulation of lncRNA MEG3 Promotes Chronic Low Dose Cadmium Exposure-Induced Cell Transformation and Cancer Stem Cell-Like Property
[Toxicology and Applied Pharmacology] The long non-coding RNA microarray analysis showed that the expression level of a tumor suppressive lncRNA maternally expressed 3 was significantly down-regulated in cadium-transformed cells, which was confirmed by further q-PCR analysis.
Dermal Cell News
Effect of Extracorporeal Shock Wave Therapy on Keratinocytes Derived from Human Hypertrophic Scars
[Scientific Reports] Keratinocytes derived from hypertrophic scar tissue were cultured and expression of proliferation markers, activation markers, differentiation markers, apoptosis factors, and proliferation/differentiation regulators was investigated to compared with that of those in keratinocytes derived from normal skin tissue.
Neural Cell News
Benzimidazoles Induce Concurrent Apoptosis and Pyroptosis of Human Glioblastoma Cells via Arresting Cell Cycle
[Acta Pharmacologica Sinica] By analyzing the hub genes of glioblastoma multiforme (GBM) via weighted gene co-expression network analysis of the cancer genome atlas dataset, and using the connectivity map platform for drug repurposing, scientists found that multiple azole compounds had potential anti-GBM activity.
Mammary Cell News
A Transcription-Based Mechanism for Oncogenic β-Catenin-Induced Lethality in BRCA1/2-Deficient Cells
[Nature Communications] Investigators reported that activation of β-catenin, an oncogene of the WNT signaling pathway, inhibited proliferation of BRCA1/2-deficient cells.
Hepatic Cell News
Downregulation of TMEM220 Promotes Tumor Progression in Hepatocellular Carcinoma
[Cancer Gene Therapy] Through overexpressing TMEM220 in hepatocellular carcinoma cell lines, scientists found that the proliferation of cancer cells was significantly slowed down and metastasis was significantly reduced.